| - GRCh37:
- Chr5:138643838
- GRCh38:
- Chr5:139308149
| MATR3 | K245I | Amyotrophic lateral sclerosis type 21 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643462
- GRCh38:
- Chr5:139307773
| MATR3 | R120G | Amyotrophic lateral sclerosis type 21 | Uncertain significance (May 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138665061
- GRCh38:
- Chr5:139329372
| MATR3 | R503G, R541G, R551G, R553G, R554G, R841G, R889G | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Dec 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643105-138665084
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658615
- GRCh38:
- Chr5:139322926
| LOC126807526, MATR3 | D365N, D403N, D415N, D416N, D703N | Amyotrophic lateral sclerosis type 21 | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138655200
- GRCh38:
- Chr5:139319511
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661179
- GRCh38:
- Chr5:139325490
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658580
- GRCh38:
- Chr5:139322891
| LOC126807526, MATR3 | G391E, G404E, G691E, G403E, G353E | Inborn genetic diseases, Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:138661147
- GRCh38:
- Chr5:139325458
| MATR3 | L385F, L423F, L436F, L771F, L723F, L433F, L435F | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643190-138643191
- GRCh38:
- Chr5:139307501-139307502
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661361
- GRCh38:
- Chr5:139325672
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138652811
- GRCh38:
- Chr5:139317122
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658416
- GRCh38:
- Chr5:139322727
| LOC126807526, MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657728
- GRCh38:
- Chr5:139322039
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643853
- GRCh38:
- Chr5:139308164
| MATR3 | Y250C | Amyotrophic lateral sclerosis type 21, Inborn genetic diseases | Uncertain significance (Nov 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:138665036
- GRCh38:
- Chr5:139329347
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657571-138657574
- GRCh38:
- Chr5:139321882-139321885
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658133
- GRCh38:
- Chr5:139322444
| LOC126807526, MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138653279
- GRCh38:
- Chr5:139317590
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643801
- GRCh38:
- Chr5:139308112
| MATR3 | D233N | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658402
- GRCh38:
- Chr5:139322713
| LOC126807526, MATR3 | G294S, G332S, G344S, G345S, G632S | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Feb 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643608
- GRCh38:
- Chr5:139307919
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643524
- GRCh38:
- Chr5:139307835
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643122
- GRCh38:
- Chr5:139307433
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138653375
- GRCh38:
- Chr5:139317686
| MATR3 | I137V, I138V, I125V, I425V, I87V | not provided, Amyotrophic lateral sclerosis type 21 | Uncertain significance (Oct 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:138655199
- GRCh38:
- Chr5:139319510
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661281
- GRCh38:
- Chr5:139325592
| MATR3 | D480E, D429E, D467E, D479E, D767E, D477E, D815E | MATR3-related condition, Amyotrophic lateral sclerosis type 21 | Uncertain significance (Feb 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:138657725
- GRCh38:
- Chr5:139322036
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657579-138657582
- GRCh38:
- Chr5:139321890-139321893
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643533
- GRCh38:
- Chr5:139307844
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643543
- GRCh38:
- Chr5:139307854
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658568
- GRCh38:
- Chr5:139322879
| LOC126807526, MATR3 | V399G, V349G, V400G, V687G, V387G | Amyotrophic lateral sclerosis type 21 | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138665073
- GRCh38:
- Chr5:139329384
| MATR3 | K507E, K545E, K555E, K557E, K558E, K845E, K893E | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657652
- GRCh38:
- Chr5:139321963
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138652777
- GRCh38:
- Chr5:139317088
| MATR3 | M389V, M51V, M101V, M102V, M89V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643851
- GRCh38:
- Chr5:139308162
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643269
- GRCh38:
- Chr5:139307580
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657570
- GRCh38:
- Chr5:139321881
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138650445
- GRCh38:
- Chr5:139314756
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658670
- GRCh38:
- Chr5:139322981
| LOC126807526, MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658524
- GRCh38:
- Chr5:139322835
| MATR3, LOC126807526 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661848
- GRCh38:
- Chr5:139326159
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Apr 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658307
- GRCh38:
- Chr5:139322618
| LOC126807526, MATR3 | D300G, D313G, D600G, D262G, D312G | Amyotrophic lateral sclerosis type 21 | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661303
- GRCh38:
- Chr5:139325614
| MATR3 | I823V, I485V, I487V, I488V, I437V, I475V, I775V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Oct 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661280
- GRCh38:
- Chr5:139325591
| MATR3 | D467V, D767V, D429V, D480V, D477V, D479V, D815V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658456
- GRCh38:
- Chr5:139322767
| LOC126807526, MATR3 | M350V, M362V, M363V, M650V, M312V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138653348
- GRCh38:
- Chr5:139317659
| MATR3 | L416I, L78I, L116I, L128I, L129I | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138655143
- GRCh38:
- Chr5:139319454
| MATR3 | P181fs, P232fs, P231fs, P519fs, P219fs | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657700
- GRCh38:
- Chr5:139322011
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643337
- GRCh38:
- Chr5:139307648
| MATR3 | T78N | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138651424
- GRCh38:
- Chr5:139315735
| MATR3 | T338R, T51R, T38R, T50R | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138644024-138644028
- GRCh38:
- Chr5:139308335-139308339
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661353-138661354
- GRCh38:
- Chr5:139325664-139325665
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661170
- GRCh38:
- Chr5:139325481
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643578
- GRCh38:
- Chr5:139307889
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661183
- GRCh38:
- Chr5:139325494
| MATR3 | I435V, I397V, I448V, I783V, I445V, I447V, I735V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138652727
- GRCh38:
- Chr5:139317038
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657626
- GRCh38:
- Chr5:139321937
| MATR3 | M261V, M548V, M210V, M248V, M260V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661857
- GRCh38:
- Chr5:139326168
| MATR3 | D505N, D455N, D841N, D506N, D793N, D493N, D503N | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658437
- GRCh38:
- Chr5:139322748
| LOC126807526, MATR3 | Q305H, Q343H, Q356H, Q355H, Q643H | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658369
- GRCh38:
- Chr5:139322680
| LOC126807526, MATR3 | S283A, S321A, S621A, S333A, S334A | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138654632
- GRCh38:
- Chr5:139318943
| MATR3 | Q160H, Q448H, Q161H, Q110H, Q148H | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jan 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661928
- GRCh38:
- Chr5:139326239
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658621
- GRCh38:
- Chr5:139322932
| LOC126807526, MATR3 | S417C, S367C, S405C, S705C, S418C | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138665021-138665024
- GRCh38:
- Chr5:139329332-139329335
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658268
- GRCh38:
- Chr5:139322579
| LOC126807526, MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Oct 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658362
- GRCh38:
- Chr5:139322673
| LOC126807526, MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138654701
- GRCh38:
- Chr5:139319012
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643566
- GRCh38:
- Chr5:139307877
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138665025-138665026
- GRCh38:
- Chr5:139329336-139329337
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657576
- GRCh38:
- Chr5:139321887
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138650417
- GRCh38:
- Chr5:139314728
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138654686
- GRCh38:
- Chr5:139318997
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643410
- GRCh38:
- Chr5:139307721
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661985
- GRCh38:
- Chr5:139326296
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643257
- GRCh38:
- Chr5:139307568
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643974
- GRCh38:
- Chr5:139308285
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138654643
- GRCh38:
- Chr5:139318954
| MATR3 | D164G, D152G, D165G, D114G, D452G | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643847
- GRCh38:
- Chr5:139308158
| MATR3 | S248I | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643982
- GRCh38:
- Chr5:139308293
| MATR3 | C293Y | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661167
- GRCh38:
- Chr5:139325478
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661165
- GRCh38:
- Chr5:139325476
| MATR3 | A429T, A441T, A442T, A777T, A439T, A729T, A391T | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661953
- GRCh38:
- Chr5:139326264
| MATR3 | P537A, P487A, P525A, P535A, P873A, P538A, P825A | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658386
- GRCh38:
- Chr5:139322697
| LOC126807526, MATR3 | E338D, E288D, E326D, E339D, E626D | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643563
- GRCh38:
- Chr5:139307874
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138651760-138651761
- GRCh38:
- Chr5:139316071-139316072
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138654671
- GRCh38:
- Chr5:139318982
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643890
- GRCh38:
- Chr5:139308201
| MATR3 | E262D | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138665079
- GRCh38:
- Chr5:139329390
| MATR3 | T547A, T559A, T557A, T560A, T509A, T847A, T895A | Amyotrophic lateral sclerosis type 21 | Uncertain significance (May 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661215
- GRCh38:
- Chr5:139325526
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jan 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138658435
- GRCh38:
- Chr5:139322746
| LOC126807526, MATR3 | Q356K, Q643K, Q355K, Q343K, Q305K | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643987
- GRCh38:
- Chr5:139308298
| MATR3 | I295V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138651440
- GRCh38:
- Chr5:139315751
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643216
- GRCh38:
- Chr5:139307527
| MATR3 | M38V | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Aug 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138654587
- GRCh38:
- Chr5:139318898
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138653347
- GRCh38:
- Chr5:139317658
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138650403
- GRCh38:
- Chr5:139314714
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643197
- GRCh38:
- Chr5:139307508
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138654620
- GRCh38:
- Chr5:139318931
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Jun 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138657737
- GRCh38:
- Chr5:139322048
| MATR3 | | Amyotrophic lateral sclerosis type 21 | Likely benign (Aug 5, 2022) | criteria provided, single submitter |